The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Cyclosporin A reverses vincristine and daunorubicin resistance in acute lymphatic leukemia in vitro.
Open accessAbstract
The development of drug resistance by tumor cells is a major obstacle to the cure of human malignancy. Cyclosporin A (CsA) completely reverses primary resistance to vincristine and cross resistance to daunorubicin in a pleiotropic drug-resistant subline of human T cell acute lymphatic leukemia. This subline is over 50-fold resistant to vincristine and fivefold resistant to daunorubicin. CsA has little effect on vincristine or daunorubicin activity in drug-sensitive parental leukemia and corrects daunorubicin resistance without altering cellular daunorubicin accumulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1981) · PubMed · Cited by 1,459
Tsuruo, T., Iida, H., Tsukagoshi, S., & Sakurai, Y. (1982) · PubMed · Cited by 659
Cyclosporin A Binding to Calmodulin: A Possible Site of Action on T Lymphocytes
Colombani, P. M., Robb, A., & Hess, A. D. (1985) · Science · doi:10.1126/science.3885394 · Cited by 279
Tsuruo, T., Iida, H., Yamashiro, M., Tsukagoshi, S., & Sakurai, Y. (1982) · Biochemical Pharmacology · doi:10.1016/0006-2952(82)90097-1 · Cited by 131
Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts.
Beck, W. T. (1983) · PubMed · Cited by 91
Promotion of daunorubicin uptake and toxicity by the calcium antagonist tiapamil and its analogs.
Kessel, D. H., & Wilberding, C. (1985) · PubMed · Cited by 35
Cited by
Schinkel, A. H., Smit, J. J. M., van Tellingen, O., Beijnen, J. H., Wagenaar, E., van Deemter, L., Mol, C. A. A. M., van der Valk, M. A., Robanus-Maandag, E. C., te Riele, H. P. J., et al. (1994) · Cell · doi:10.1016/0092-8674(94)90212-7 · Cited by 2,281
Schinkel, A. H., Wagenaar, E., van Deemter, L., Mol, C. A., & Borst, P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118214 · Cited by 1,107
Human P-glycoprotein transports cyclosporin A and FK506.
Saeki, T., Ueda, K., Tanigawara, Y., Hori, R., & Komano, T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53221-x · Cited by 684
Mechanism of multidrug resistance
Bradley, G., Juranka, P. F., & Ling, V. (1988) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(88)90006-6 · Cited by 617
Ito, K., Iwatsubo, T., Kanamitsu, S., Ueda, K., Suzuki, H., & Sugiyama, Y. (1998) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01372-3 · Cited by 512
P-Glycoprotein Expression as a Predictor of the Outcome of Therapy for Neuroblastoma
Chan, H. S. L., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N., Yeger, H., & Ling, V. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112053252304 · Cited by 441
List, A. F., Kopecky, K. J., Willman, C. L., Head, D. R., Persons, D. L., Slovak, M. L., Dorr, R., Karanes, C., Hynes, H. E., Doroshow, J. H., et al. (2001) · Blood · doi:10.1182/blood.v98.12.3212 · Cited by 419
Marie, J., Zittoun, R., & Sikic, B. (1991) · Blood · doi:10.1182/blood.v78.3.586.586 · Cited by 394
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Silva, R., Vilas-Boas, V., Carmo, H., Dinis-Oliveira, R. J., Carvalho, F., de Lourdes Bastos, M., & Remião, F. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.11.013 · Cited by 339
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
Rowinsky, E. K., & Donehower, R. C. (1991) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(91)90086-2 · Cited by 321
Calcein accumulation as a fluorometric functional assay of the multidrug transporter
Holló, Z., Homolya, L., Davis, C. W., & Sarkadi, B. (1994) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(94)90190-2 · Cited by 315
Lum, B. L., Kaubisch, S., Yahanda, A. M., Adler, K. M., Jew, L., Ehsan, M. N., Brophy, N. A., Halsey, J., Gosland, M. P., & Sikic, B. I. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.10.1635 · Cited by 299
Lavie, Y., Cao, H.-T., Volner, A., Lucci, A., Han, T.-Y., Geffen, V., Giuliano, A. E., & Cabot, M. C. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.3.1682 · Cited by 284
Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.
List, A. F., Spier, C., Greer, J., Wolff, S., Hutter, J., Dorr, R., Salmon, S., Futscher, B., Baier, M., & Dalton, W. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.9.1652 · Cited by 274
Metadata
- Authors
- Slater, L. M., Sweet, P., Stupecky, M., & Gupta, S.
- Venue
- Journal of Clinical Investigation
- Published
- 1986-04-01
- Volume
- 77
- Issue
- 4
- Pages
- 1405-1408
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2063578373
- Cited by
- 316
- References
- 6
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.